These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19734408)

  • 21. Treatment of attention deficit hyperactivity disorder in adults.
    Greenfield B; Hechman L
    Expert Rev Neurother; 2005 Jan; 5(1):107-21. PubMed ID: 15853481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive predisposition to substance abuse in adult attention deficit hyperactivity disorder.
    Sharps MJ; Price-Sharps JL; Day SS; Villegas AB; Nunes MA
    Addict Behav; 2005 Feb; 30(2):355-9. PubMed ID: 15621407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
    Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
    Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.
    Findling RL; Biederman J; Wilens TE; Spencer TJ; McGough JJ; Lopez FA; Tulloch SJ;
    J Pediatr; 2005 Sep; 147(3):348-54. PubMed ID: 16182674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family abuse of methylphenidate.
    Fulton AI; Yates WR
    Am Fam Physician; 1988 Aug; 38(2):143-5. PubMed ID: 3407585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attention deficit hyperactivity disorder in adults].
    Roizblatt A; Bustamante F; Bacigalupo F
    Rev Med Chil; 2003 Oct; 131(10):1195-201. PubMed ID: 14692312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adderall.
    Med Lett Drugs Ther; 2005 Mar; 47(1205):28. PubMed ID: 15795685
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonmedical use of prescription stimulants in the United States.
    Kroutil LA; Van Brunt DL; Herman-Stahl MA; Heller DC; Bray RM; Penne MA
    Drug Alcohol Depend; 2006 Sep; 84(2):135-43. PubMed ID: 16480836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse in adolescents: diagnostic issues derived from studies of attention deficit disorder with hyperactivity.
    Loney J
    NIDA Res Monogr; 1988; 77():19-26. PubMed ID: 3145426
    [No Abstract]   [Full Text] [Related]  

  • 33. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school.
    Scheffler RM; Brown TT; Fulton BD; Hinshaw SP; Levine P; Stone S
    Pediatrics; 2009 May; 123(5):1273-9. PubMed ID: 19403491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product.
    Levisky JA; Karch SB; Bowerman DL; Jenkins WW; Johnson DG; Davies D
    J Anal Toxicol; 2003 Mar; 27(2):123-4. PubMed ID: 12670009
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of Trends of Near-Real-Time Urine Drug Test Results for Methamphetamine, Cocaine, Heroin, and Fentanyl.
    Twillman RK; Dawson E; LaRue L; Guevara MG; Whitley P; Huskey A
    JAMA Netw Open; 2020 Jan; 3(1):e1918514. PubMed ID: 31899527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High concentrations of dextromethorphan result in false-positive in opiate immunoassay test.
    Finn N; Wolf J; Louie J; Su B
    Clin Chim Acta; 2015 Aug; 448():247. PubMed ID: 26192219
    [No Abstract]   [Full Text] [Related]  

  • 38. Interference of alum on analysis of methamphetamine in urine specimens.
    Liu CY; Chien CS
    Clin Chem; 1996 Feb; 42(2):338-40. PubMed ID: 8595740
    [No Abstract]   [Full Text] [Related]  

  • 39. False-positive for (+)-methamphetamine.
    Solomon MD; Wright JA
    Clin Chem; 1977 Aug; 23(8):1504. PubMed ID: 872410
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of alum on methamphetamine screening tests.
    Kaufman MS; Hubbs LM; Melander K
    Clin Chem; 1996 Oct; 42(10):1720-1. PubMed ID: 8855165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.